AI is reshaping Agile development. Here's how teams can boost productivity and quality while avoiding the biggest risks.

Eva-Maria Hempe, NVIDIA, says bio/pharma must centralize AI strategy, tackle silos, prioritize process integrity, and balance quick wins with long-term drug design goals.

The global pharmaceutical industry gathers this week at CPHI Frankfurt 2025 from October 28–30. As a global leading ...

Curia’s global API aseptic processing manufacturing network has served a broad portfolio of customers worldwide for more than 20 years. This investment positions the company to support increasingly ...

Regulatory scrutiny on traditional excipients like titanium dioxide and talc poses significant challenges, necessitating robust scientific evidence to address concerns. Sustainable practices in ...

Microsoft and OpenAI have renegotiated their collaboration. The partnership will be more flexible, giving both companies more ...

Agents can now use Mavis to search for a customer and find important information, such as their cover entitlements, which can ...

With the rise in adoption of agentic AI by companies for automation and increasing complexities of the newer versions, ...

AI agents are entering the crypto trading and payments space, but experts warn it can introduce new risks, ranging from hacks ...

Developers aren’t waiting while leadership dithers over a standardized, official AI platform. Better to treat a platform as a ...

The answer is that new versions of Web APIs, such as the DOM, are not needed to make them usable from Wasm; the existing ...

Microsoft and OpenAI have entered a new phase of their partnership, signing a definitive agreement that redefines their collaboration and ownership structure.